Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed later-stage tilt small index

Cataracts: later-stage trial registry

A small indexed set (9 trials) with no open enrollment listed right now.

Corpus placement: #1,916 of 28,707 conditions by registered trial count.

9 US clinical trials · none currently recruiting · #1,916 of 28,707 conditions by registered trial count

Cataracts: 9 US clinical trials tracked, none currently recruiting.

Cataracts is the subject of 9 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 7 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Innovative Medical, running 3 of these trials.

Enrollment posture brief

Registry condition cataracts

OPEN 0 | RECR 0% | LATE 7 | EARLY 0 | RANK #1916 | SPON 3

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Acute Lymphoblastic Leukemia55.6%Acute Respiratory Distress S55.6%Acute Otitis Media22.2%Acute Heart Failure11.1%Cataracts (this)0%
Open-enrollment share among volume-matched conditions near Cataracts

Cataracts has no open enrollment in this registry pull (9 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Cataracts on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Cataracts is recruiting below its size-band peers.

    0 of 9 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Cataracts research.

    Innovative Medical accounts for 3 of 9 trials (33.3%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Typical Cataracts enrolment sits around 95 participants.

    Median target enrolment is 95 among the 9 trials that report a genuine target (sentinel values excluded). 5 of those (55.6%) plan for fewer than 100 participants.

  4. Cataracts research is mostly interventional.

    9 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 31Phase 46

Indexed trials (enrollment closed)

9 total, page 1 of 1

COMPLETED Phase 3 173 participants

DisCoVisc Comparative Evaluation

Alcon Research

NCT00732225

COMPLETED Phase 4 126 participants

A Comparison of Peak Aqueous Penetration of Acuvail (Ketorolac 0.45%), Xibrom (Bromfenac 0.09%), and Nevanac (Nepafenac 0.1%)in Patients Undergoing Phacoemulsification

Frank A. Bucci, Jr., M.D.

NCT01001806

COMPLETED Phase 4 120 participants

Aqueous Absorption and Pharmacokinetics of Besivance Versus VIGAMOX in Patients Undergoing Phacoemulsification

Frank A. Bucci, Jr., M.D.

NCT01296191

COMPLETED NA 117 participants

A Post-Market Evaluation of LipiFlow Treatment in Cataract Surgery Practice

Johnson & Johnson Surgical Vision

NCT03708367

COMPLETED NA 95 participants

Intraocular Pressure Control Following One Site Versus Two Site Combined Phacoemulsification/IOL And Trabeculectomy

Lahey Clinic

NCT00695747

COMPLETED Phase 4 50 participants

Dispervise Ophthalmic Viscoelastic as an Agent to Ensure Watertight Wound Closure After Clear Corneal Cataract Incisions

Innovative Medical

NCT01298973

COMPLETED Phase 4 49 participants

Determination of Optimum Duration of Treatment With Bromfenac (Xibrom) Eyedrops Following Cataract Surgery

Bp Consulting

NCT00758199

COMPLETED Phase 4 29 participants

Clear Corneal Incisions and Arcuate Incisions Utilizing FemtoSecond Laser Technology for Cataract Surgery

Innovative Medical

NCT01383057

COMPLETED Phase 4 25 participants

Randomized Comparison of the Abbott WHITESTAR Signature System With Ellips Tranversal Ultrasound vs. the Alcon Infiniti With the Ozil Torsional Handpiece in Phacoemulsification: A Contralaterally-Controlled Trial

Innovative Medical

NCT01279031

Phase Distribution

PhaseTrial count
Phase 3 1
Phase 4 6

Named interventions

Most-linked intervention names on Cataracts records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Alcon Infiniti wiht the OZIL Torsional Handpiece Device
1 trials
Abbott WHITESTAR Signature System with Ellips Transversal Ultrasound Device
1 trials
bromfenac 0.09% Drug
1 trials
Ketorolac Tromethamine 0.45% Drug
1 trials
Amvisc Plus Device
1 trials
Healon5 Device
1 trials
BioVisc Device
1 trials
DuoVisc Device
1 trials

US sites by state

Facility locations filed on Cataracts trials. A trial with sites in several states counts in each.

California 3 trials
Texas 2 trials
Pennsylvania 2 trials
Tennessee 1 trials
New Jersey 1 trials
Maryland 1 trials
Massachusetts 1 trials
Florida 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Cataracts page

9 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Cataracts trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Innovative Medical sponsors the most Cataracts trials on record, review their full trial history before evaluating a specific study. See Innovative Medical's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cataracts condition card totals 9 registered trials; most-linked intervention Alcon Infiniti wiht the OZIL Torsional Handpiece; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.